BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 29029513)

  • 1. Development of mesenchymal subtype gene signature for clinical application in gastric cancer.
    Lee J; Cristescu R; Kim KM; Kim K; Kim ST; Park SH; Kang WK
    Oncotarget; 2017 Sep; 8(39):66305-66315. PubMed ID: 29029513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of Radiotherapy for Mesenchymal and Non-Mesenchymal Subtypes of Gastric Cancer.
    Yu JI; Park HC; Lee J; Choi C; Kang WK; Park SH; Kim ST; Sohn TS; Lee JH; An JY; Choi MG; Bae JM; Kim KM; Han H; Kim K; Kim S; Lim DH
    Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32290335
    [No Abstract]   [Full Text] [Related]  

  • 3. GeneExpressScore Signature: a robust prognostic and predictive classifier in gastric cancer.
    Zhu X; Tian X; Sun T; Yu C; Cao Y; Yan T; Shen C; Lin Y; Fang JY; Hong J; Chen H
    Mol Oncol; 2018 Nov; 12(11):1871-1883. PubMed ID: 29957874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular classification of esophagogastric junction carcinoma correlated with prognosis.
    Zou L; Wu Y; Ma K; Fan Y; Dong D; Geng N; Li E
    Onco Targets Ther; 2017; 10():4765-4772. PubMed ID: 29026322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics and prognostic significance of TCGA and ACRG classification in gastric cancer among the Chinese population.
    Wang Q; Xie Q; Liu Y; Guo H; Ren Y; Li J; Zhao Q
    Mol Med Rep; 2020 Aug; 22(2):828-840. PubMed ID: 32468041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastric cancer molecular classification based on immunohistochemistry and in situ hybridization: Analysis in western patients after curative-intent surgery.
    Ramos MFKP; Pereira MA; de Mello ES; Cirqueira CDS; Zilberstein B; Alves VAF; Ribeiro-Junior U; Cecconello I
    World J Clin Oncol; 2021 Aug; 12(8):688-701. PubMed ID: 34513602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular classification of gastric cancer predicts survival in patients undergoing radical gastrectomy based on project HOPE.
    Furukawa K; Hatakeyama K; Terashima M; Nagashima T; Urakami K; Ohshima K; Notsu A; Sugino T; Yagi T; Fujiya K; Kamiya S; Hikage M; Tanizawa Y; Bando E; Kanai Y; Akiyama Y; Yamaguchi K
    Gastric Cancer; 2022 Jan; 25(1):138-148. PubMed ID: 34476642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular and Clinical Characterization of a Claudin-Low Subtype of Gastric Cancer.
    Nishijima TF; Kardos J; Chai S; Smith CC; Bortone DS; Selitsky SR; Parker JS; Sanoff HK; Lee MS; Vincent BG
    JCO Precis Oncol; 2017 Nov; 1():1-10. PubMed ID: 35172495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Composite Gene Expression Signature Optimizes Prediction of Colorectal Cancer Metastasis and Outcome.
    Schell MJ; Yang M; Missiaglia E; Delorenzi M; Soneson C; Yue B; Nebozhyn MV; Loboda A; Bloom G; Yeatman TJ
    Clin Cancer Res; 2016 Feb; 22(3):734-45. PubMed ID: 26446941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reproduction of molecular subtypes of gastric adenocarcinoma by transcriptome sequencing of archival tissue.
    Heo YJ; Park C; Yu D; Lee J; Kim KM
    Sci Rep; 2019 Jul; 9(1):9675. PubMed ID: 31273278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metastasis Related Epithelial-Mesenchymal Transition Signature Predicts Prognosis and Response to Immunotherapy in Gastric Cancer.
    Song J; Wei R; Huo S; Gao J; Liu X
    Front Immunol; 2022; 13():920512. PubMed ID: 35769483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular subtyping of gastric cancer according to ACRG using immunohistochemistry - Correlation with clinical parameters.
    Pretzsch E; Bösch F; Todorova R; Nieß H; Jacob S; Guba M; Kirchner T; Werner J; Klauschen F; Angele MK; Neumann J
    Pathol Res Pract; 2022 Mar; 231():153797. PubMed ID: 35151032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NanoString expression profiling identifies candidate biomarkers of RAD001 response in metastatic gastric cancer.
    Das K; Chan XB; Epstein D; Te Teh B; Kim KM; Kim ST; Park SH; Kang WK; Rozen S; Lee J; Tan P
    ESMO Open; 2016; 1(1):e000009. PubMed ID: 27843583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening of Differentially Expressed Genes Based on the ACRG Molecular Subtypes of Gastric Cancer and the Significance and Mechanism of
    Zhang H; Zhen S; Ding P; Tan B; Wang H; Liu W; Tian Y; Zhao Q
    J Pers Med; 2023 Mar; 13(3):. PubMed ID: 36983741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strong Prognostic Value of Microsatellite Instability in Intestinal Type Non-cardia Gastric Cancer.
    Marrelli D; Polom K; Pascale V; Vindigni C; Piagnerelli R; De Franco L; Ferrara F; Roviello G; Garosi L; Petrioli R; Roviello F
    Ann Surg Oncol; 2016 Mar; 23(3):943-50. PubMed ID: 26530444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated Analysis Identifies an Immune-Based Prognostic Signature for the Mesenchymal Identity in Gastric Cancer.
    Peng D; Gu B; Ruan L; Zhang X; Shu P
    Biomed Res Int; 2020; 2020():9780981. PubMed ID: 32352015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Host immune response index in gastric cancer identified by comprehensive analyses of tumor immunity.
    Park C; Cho J; Lee J; Kang SY; An JY; Choi MG; Lee JH; Sohn TS; Bae JM; Kim S; Kim ST; Park SH; Park JO; Kang WK; Sohn I; Jung SH; Kang MS; Kim KM
    Oncoimmunology; 2017; 6(11):e1356150. PubMed ID: 29147610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrative network analysis identifies an immune-based prognostic signature as the determinant for the mesenchymal subtype in epithelial ovarian cancer.
    Sheng M; Tong H; Lu X; Shanshan N; Zhang X; Reddy BA; Shu P
    Medicine (Baltimore); 2020 Oct; 99(41):e22549. PubMed ID: 33031300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Gene Signature Derived from the Loss of CDKN1A (p21) Is Associated with CMS4 Colorectal Cancer.
    Bueno-Fortes S; Muenzner JK; Berral-Gonzalez A; Hampel C; Lindner P; Berninger A; Huebner K; Kunze P; Bäuerle T; Erlenbach-Wuensch K; Sánchez-Santos JM; Hartmann A; De Las Rivas J; Schneider-Stock R
    Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated microRNA network analyses identify a poor-prognosis subtype of gastric cancer characterized by the miR-200 family.
    Song F; Yang D; Liu B; Guo Y; Zheng H; Li L; Wang T; Yu J; Zhao Y; Niu R; Liang H; Winkler H; Zhang W; Hao X; Chen K
    Clin Cancer Res; 2014 Feb; 20(4):878-89. PubMed ID: 24352645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.